Tag archive for ‘Heather Bresch’
Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...

Niva Goldberg On Thursday, June 18th, 2015

U.S. court invalidates Teva’s Copaxone patent

The U.S. Court of Appeals has again ruled that Teva Pharmaceuticals Industries Ltd.’s patent for its top-selling multiple sclerosis treatment Copaxone is invalid. A Teva spokeswoman said that the company is More...

Three way takeover battle: Abbott Labs to back Mylan’s acquisition of Perrigo

Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott Lab potentially helping Mylan forfend More...

Shiri Habib-Valdhorn On Monday, June 15th, 2015

Three Way Takeover Battle: Statistics weigh against Teva’s Mylan bid succeeding

  Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover More...

Clive Minchom On Monday, June 8th, 2015

Teva Issues New Letter to Mylan NV Confirming Seriousness Of Offer To Acquire Mylan

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) issued a new open letter on Monday, signed by both the Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, addressed to More...

Ilan Shavit On Tuesday, June 2nd, 2015

Mylan to Teva: stop playing games with our company

Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule More...

Niva Goldberg On Saturday, May 30th, 2015

Mylan’s CEO on Teva “They are getting ready to go off the cliff”

“We just don’t think Teva is the right company” to combine with, “They are getting ready to go off the cliff, ” Mylan NV, CEO Heather Bresch said Friday at a conference in New York City hosted More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Koby Yeshayahou On Tuesday, May 12th, 2015

Three Way Takeover Battle: Mylan mulling improved offer for Perrigo – Bloomberg

Mylan (MYL) is considering an improved offer to shareholders of Perrigo (PRGO) with the aim of acquiring the company and thus heading off the hostile bid for Mylan from Teva Pharmaceutical Industries Ltd. (NYSE: More...

Koby Yeshayahou On Wednesday, May 6th, 2015

Teva takeover supporter Paulson raises Mylan stake

  John Paulson‘s hedge fund has increased its holdings in Mylan NV to 4.5%. The fund, which supports Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA; TASE: TEVA) takeover bid for Mylan, More...

Globes On Sunday, July 28th, 2013

Teva loses Copaxone patent appeal

– The decision maintains exclusivity for Copaxone until May 24, 2014. – Copaxone/ source : dynamik3d.ca – On Friday, the US Court of Appeals for the Federal Circuit ruled in favor of More...

Wordpress site Developed by Fixing WordPress Problems